BioRestorative Announces Share Repurchase Program
OrthoSpineNews
JUNE 17, 2025
We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient’s damaged disc. We have also obtained U.S.
52 
Let's personalize your content